Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Connect Biopharma Holdings (CNTB)
NASDAQ:CNTB
RESEARCH TOOLSreports
Connect Biopharma Holdings (CNTB) Stock Price & Analysis
53 Followers
CNTB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.53 - $2.84
Previous Close$1.72
Volume194.95K
Average Volume (3M)164.47K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)¥550.27M
Total Debt (Recent Filing)¥3.00M
Price to Earnings (P/E)-1.1
Beta0.45
Next Earnings
Sep 10, 2024EPS Estimate
-$0.46Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.58
Shares Outstanding55,041,247
10 Day Avg. Volume324,304
30 Day Avg. Volume164,470
Standard Deviation0.30
R-Squared0.01
Alpha-0.00764
Financial Highlights & Ratios
Price to Book (P/B)0.78
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$6.50Price Target Upside277.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Connect Biopharma Holdings News
Ownership Overview
0.00%
Insiders
0.08% Mutual Funds
10.34% Other Institutional Investors
89.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CNTB FAQ
What was Connect Biopharma Holdings’s price range in the past 12 months?
Connect Biopharma Holdings lowest stock price was $0.53 and its highest was $2.84 in the past 12 months.
What is Connect Biopharma Holdings’s market cap?
Currently, no data Available
When is Connect Biopharma Holdings’s upcoming earnings report date?
Connect Biopharma Holdings’s upcoming earnings report date is Sep 10, 2024 which is in 144 days.
How were Connect Biopharma Holdings’s earnings last quarter?
Connect Biopharma Holdings released its earnings results on Mar 28, 2024. The company reported -$0.228 earnings per share for the quarter, the consensus estimate of -$0.228 by $0.
Is Connect Biopharma Holdings overvalued?
According to Wall Street analysts Connect Biopharma Holdings’s price is currently Undervalued.
Does Connect Biopharma Holdings pay dividends?
Connect Biopharma Holdings does not currently pay dividends.
What is Connect Biopharma Holdings’s EPS estimate?
Connect Biopharma Holdings’s EPS estimate is -$0.46.
How many shares outstanding does Connect Biopharma Holdings have?
Connect Biopharma Holdings has 55,071,560 shares outstanding.
What happened to Connect Biopharma Holdings’s price movement after its last earnings report?
Connect Biopharma Holdings reported an EPS of -$0.228 in its last earnings report, expectations of -$0.228. Following the earnings report the stock price went up 8.075%.
Which hedge fund is a major shareholder of Connect Biopharma Holdings?
Among the largest hedge funds holding Connect Biopharma Holdings’s share is RA Capital Management. It holds Connect Biopharma Holdings’s shares valued at 4M.
---
Connect Biopharma Holdings Stock Smart Score
Company Description
Connect Biopharma Holdings
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307, CBP-174, and CBP-233.
---
CNTB Stock 12 Months Forecast
Average Price Target
$6.50
▲(277.91% Upside)
Technical Analysis
Best Analysts Covering CNTB
1 Year
1 Year Success Rate
7/17 ratings generated profit
1 Year Average Return
-8.30%
reiterated a buy rating 10 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -8.30% per trade.
---